Dolutegravir Tied To Greater Viral Suppression For Pregnant Patients With HIV-1, Study Finds

September 01, 2022

MedPage Today (8/31, D'Ambrosio) reports, “The HIV agent dolutegravir (Tivicay) was tied to greater viral suppression for pregnant patients with HIV-1, according to a cohort study.” Among those “who used dolutegravir during pregnancy, viral suppression at...